Genetic testing and Parkinson disease: Assessment of patient knowledge, attitudes, and interest

Journal of Genetic Counseling

Volumn 20, Issue 4, 2011, Pages 384-395

  Falcone, Dana Clay ^a   Wood, Elisabeth McCarty ^a   Xie, Sharon X ^b   Siderowf, Andrew ^c   Van Deerlin, Vivianna M ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c PENNSYLVANIA HOSPITAL   (United States)

Author keywords

Attitudes; Genetic knowledge; Genetic testing; Parkinson disease; Perceived risk

Indexed keywords

ADULT; AGED; ARTICLE; ATTITUDE TO HEALTH; FEMALE; GENETIC SCREENING; GENETICS; HUMAN; MALE; PARKINSON DISEASE; PATIENT; PSYCHOLOGICAL ASPECT;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; GENETIC TESTING; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MALE; PARKINSON DISEASE; PATIENTS;

EID: 80052608877     PISSN: 10597700     EISSN: 15733599     Source Type: Journal    
DOI: 10.1007/s10897-011-9362-0     Document Type: Article

References (47)

1. Armstrong, K., Calzone, K., Stopfer, J., Fitzgerald, G., Coyne, J., & Weber, B. (2000). Factors associated with decisions about clinical BRCA1/2 testing. Cancer Epidemiology, Biomarkers & Prevention, 9(11), 1251-1254.
2. Biggins, C. A., Boyd, J. L., Harrop, F. M., Madeley, P., Mindham, R. H., Randall, J. I., et al. (1992). A controlled, longitudinal study of dementia in Parkinson's disease. Journal of Neurology, Neurosurgery and Psychiatry, 55(7), 566-571.
3. Bowling, B. V., Acra, E. E., Wang, L., Myers, M. F., Dean, G. E., Markle, G. C., et al. (2008). Development and evaluation of a genetics literacy assessment instrument for undergraduates. Genetics, 178(1), 15-22. (Pubitemid 351398727)
4. Cameron, L. D., Sherman, K. A., Marteau, T. M., & Brown, P. M. (2009). Impact of genetic risk information and type of disease on perceived risk, anticipated affect, and expected consequences of genetic tests. Health Psychology, 28(3), 307-316.
5. Cappelli, M., Surh, L., Humphreys, L., Verma, S., Logan, D., Hunter, A., et al. (1999). Psychological and social determinants of women's decisions to undergo genetic counseling and testing for breast cancer. Clinical Genetics, 55(6), 419-430. (Pubitemid 29335638)
6. Croyle, R. T., & Lerman, C. (1999). Risk communication in genetic testing for cancer susceptibility. Journal of the National Cancer Institute Monographs (25), 59-66.
7. Dahodwala, N., Connolly, J., Farmer, J., Stern, M. B., Jennings, D., & Siderowf, A. (2007). Interest in predictive testing for Parkinson's disease: Impact of neuroprotective therapy. Parkinsonism & Related Disorders, 13(8), 495-499. (Pubitemid 350102306)
8. Daly, M. B., Lerman, C. L., Ross, E., Schwartz, M. D., Sands, C. B., & Masny, A. (1996). Gail model breast cancer risk components are poor predictors of risk perception and screening behavior. Breast Cancer Research and Treatment, 41(1), 59-70. (Pubitemid 26360135)
9. de Lau, L. M., Schipper, C. M., Hofman, A., Koudstaal, P. J., & Breteler, M. M. (2005). Prognosis of Parkinson disease: Risk of dementia and mortality: The Rotterdam Study. Archives of Neurology, 62(8), 1265-1269. (Pubitemid 41168354)
10. Elbaz, A., Grigoletto, F., Baldereschi, M., Breteler, M. M., Manubens- Bertran, J. M., Lopez-Pousa, S., et al. (1999). Familial aggregation of Parkinson's disease: A population-based casecontrol study in Europe. EUROPARKINSON Study Group. Neurology, 52(9), 1876-1882. (Pubitemid 29260903)
11. Farrer, M., Stone, J., Mata, I. F., Lincoln, S., Kachergus, J., Hulihan, M., et al. (2005). LRRK2 mutations in Parkinson disease. Neurology, 65(5), 738-740. (Pubitemid 41285854)
12. Flesch, R. (1948). A new readability yardstick. The Journal of Applied Psychology, 32(3), 221-233.
13. Goldwurm, S., Zini, M., Mariani, L., Tesei, S., Miceli, R., Sironi, F., et al. (2007). Evaluation of LRRK2 G2019S penetrance: Relevance for genetic counseling in Parkinson disease. Neurology, 68(14), 1141-1143. (Pubitemid 46559849)
14. Healy, D. G., Falchi, M., O'Sullivan, S. S., Bonifati, V., Durr, A., Bressman, S., et al. (2008). Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: A case-control study. Lancet Neurology, 7(7), 583-590.
15. Hoops, S., Nazem, S., Siderowf, A. D., Duda, J. E., Xie, S. X., Stern, M. B., et al. (2009). Validity of the MoCA and MMSE in the detection of MCI and dementia in Parkinson disease. Neurology, 73(21), 1738-1745.
16. Houfek, J. F., Atwood, J. R., Wolfe, R. M., Agrawal, S., Reiser, G. M., Schaefer, G. B., et al. (2008). Knowledge and beliefs about genetics and smoking among visitors and staff at a health care facility. Public Health Nursing, 25(1), 77-87.
17. Ishiyama, I., Nagai, A., Muto, K., Tamakoshi, A., Kokado, M., Mimura, K., et al. (2008). Relationship between public attitudes toward genomic studies related to medicine and their level of genomic literacy in Japan. American Journal of Medical Genetics. Part A, 146A(13), 1696-1706. (Pubitemid 351975480)
18. Kay, D. M., Bird, T. D., Zabetian, C. P., Factor, S. A., Samii, A., Higgins, D. S., et al. (2006). Validity and utility of a LRRK2 G2019S mutation test for the diagnosis of Parkinson's disease. Genetic Testing, 10(3), 221-227. (Pubitemid 44849892)
19. Kelly, K., Leventhal, H., Marvin, M., Toppmeyer, D., Baran, J., & Schwalb, M. (2004). Cancer genetics knowledge and beliefs and receipt of results in Ashkenazi Jewish individuals receiving counseling for BRCA1/2 mutations. Cancer Control, 11(4), 236-244. (Pubitemid 38970625)
20. Kincaid, J. P., Fishburne R. P. Jr., Rogers, R. L., Chissom, B. S. (1975). Derivation of new readability formulas (Automated Readability Index, Fog Count and Flesch Reading Ease Formula) for Navy enlisted personnel. Research Branch Report. Millington, TN: Naval Technical Training Command, 8-75.
21. Klein, C. (2006). Implications of genetics on the diagnosis and care of patients with Parkinson disease. Archives of Neurology, 63(3), 328-334.
22. Klein, C., & Schlossmacher, M. G. (2006). The genetics of Parkinson disease: Implications for neurological care. Nature Clinical Practice. Neurology, 2(3), 136-146.
23. Klitzman, R. L. (2010). Misunderstandings concerning genetics among patients confronting genetic disease. Journal of Genetic Counseling, 19(5), 430-446.
24. Lewis, J. R., Konda, V., & Rubin, D. T. (2009). Genetic testing for inflammatory bowel disease: Focus group analysis of patients and family members. Genetic Testing and Molecular Biomarkers, 13 (4), 495-503.
25. Manne, S. L., Chung,D. C.,Weinberg,D. S.,Vig, H. S., Catts, Z., Cabral, M. K., et al. (2007). Knowledge and attitudes about microsatellite instability testing among high-risk individuals diagnosed with colorectal cancer. Cancer Epidemiology, Biomarkers & Prevention, 16(10), 2110-2117. (Pubitemid 47621188)
26. Marder, K., Levy, G., Louis, E. D.,Mejia-Santana, H., Cote, L.,Andrews, H., et al. (2003). Familial aggregation of early- and late-onset Parkinson's disease. Annals of Neurology, 54(4), 507-513. (Pubitemid 37176547)
27. Mayeux, R., Denaro, J., Hemenegildo, N., Marder, K., Tang, M. X., Cote, L. J., et al. (1992). A population-based investigation of Parkinson's disease with and without dementia. Relationship to age and gender. Archives of Neurology, 49(5), 492-497.
28. McDaniel, S. H. (2005). The psychotherapy of genetics. Family Process, 44(1), 25-44.
29. McInerney-Leo, A. (2005). Genetic testing in Parkinson's disease. Movement Disorders, 20(7), 908-909.
30. McInerney-Leo, A., Hadley, D. W., Gwinn-Hardy, K., & Hardy, J. (2005). Genetic testing in Parkinson's disease. Movement Disorders, 20(1), 1-10. (Pubitemid 40277497)
31. Morren, M., Rijken, M., Baanders, A. N., & Bensing, J. (2007). Perceived genetic knowledge, attitudes towards genetic testing, and the relationship between these among patients with a chronic disease. Patient Education and Counseling, 65(2), 197-204. (Pubitemid 46073559)
32. Moscarillo, T. J., Holt, H., Perman, M., Goldberg, S., Cortellini, L., Stoler, J. M., et al. (2007). Knowledge of and attitudes about Alzheimer disease genetics: Report of a pilot survey and two focus groups. Community Genetics, 10(2), 97-102. (Pubitemid 46474698)
33. Nasreddine, Z. S., Phillips, N. A., Bedirian, V., Charbonneau, S., Whitehead, V., Collin, I., et al. (2005). The Montreal Cognitive Assessment, MoCA: A brief screening tool for mild cognitive impairment. Journal of the American Geriatrics Society, 53(4), 695-699. (Pubitemid 41623495)
34. Ozelius, L. J., Senthil, G., Saunders-Pullman, R., Ohmann, E., Deligtisch, A., Tagliati, M., et al. (2006). LRRK2 G2019S as a cause of Parkinson's disease in Ashkenazi Jews. The New England Journal of Medicine, 354(4), 424-425. (Pubitemid 43145083)
35. Paisan-Ruiz, C., Jain, S., Evans, E. W., Gilks, W. P., Simon, J., van der Brug, M., et al. (2004). Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease. Neuron, 44(4), 595-600. (Pubitemid 39531224)
36. Poewe, W., & Mahlknecht, P. (2009). The clinical progression of Parkinson's disease. Parkinsonism & Related Disorders, 15 (Suppl 4), S28-S32.
37. Prakash, K. M., Lum, S. Y., Fook-Choong, S., & Tan, E. K. (2006). Knowledge about the genetics of essential tremor in patients and their relatives. European Journal of Neurology, 13(11), 1266-1269. (Pubitemid 44581478)
38. Rantala, J., Platten, U., Lindgren, G., Nilsson, B., Arver, B., Lindblom, A., et al. (2009). Risk perception after genetic counseling in patients with increased risk of cancer. Hereditary Cancer in Clinical Practice, 7(1), 15.
39. Rose, A., Peters, N., Shea, J. A., & Armstrong, K. (2005). The association between knowledge and attitudes about genetic testing for cancer risk in the United States. Journal of Health Communication, 10(4), 309-321. (Pubitemid 40980947)
40. Tan, E. K., & Jankovic, J. (2006). Genetic testing in Parkinson disease: Promises and pitfalls. Archives of Neurology, 63(9), 1232-1237. (Pubitemid 44379821)
41. Tan, E. K., Lee, J., Hunter, C., Shinawi, L., Fook-Chong, S., & Jankovic, J. (2007). Comparing knowledge and attitudes towards genetic testing in Parkinson's disease in an American and Asian population. Journal of the Neurological Sciences, 252(2), 113-120. (Pubitemid 46048642)
42. Taylor, C. A., Saint-Hilaire, M. H., Cupples, L. A., Thomas, C. A., Burchard, A. E., Feldman, R. G., et al. (1999). Environmental, medical, and family history risk factors for Parkinson's disease: A New England-based case control study. American Journal of Medical Genetics, 88(6), 742-749.
43. Tison, F., Dartigues, J. F., Auriacombe, S., Letenneur, L., Boller, F., & Alperovitch, A. (1995). Dementia in Parkinson's disease: A population-based study in ambulatory and institutionalized individuals. Neurology, 45(4), 705-708.
44. Uitti, R. J., Baba, Y., Wszolek, Z. K., & Putzke, D. J. (2005). Defining the Parkinson's disease phenotype: Initial symptoms and baseline characteristics in a clinical cohort. Parkinsonism & Related Disorders, 11(3), 139-145.
45. Watner, D., Jurewicz, E. C., & Louis, E. D. (2002). Survey of essential tremor patients on their knowledge about the genetics of the disease. Movement Disorders, 17(2), 378-381. (Pubitemid 36041309)
46. Zeger, S. L., Liang, K. Y., & Albert, P. S. (1988). Models for longitudinal data: A generalized estimating equation approach. Biometrics, 44(4), 1049-1060. (Pubitemid 19026037)
47. Zimprich, A., Biskup, S., Leitner, P., Lichtner, P., Farrer, M., Lincoln, S., et al. (2004). Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology. Neuron, 44(4), 601-607. (Pubitemid 39531225)